TY  - GEN
AU  - Dieli,Francesco
AU  - Vermijlen,David
AU  - Fulfaro,Fabio
AU  - Caccamo,Nadia
AU  - Meraviglia,Serena
AU  - Cicero,Giuseppe
AU  - Roberts,Andrew
AU  - Buccheri,Simona
AU  - D'Asaro,Matilde
AU  - Gebbia,Nicola
AU  - Salerno,Alfredo
AU  - Eberl,Matthias
AU  - Hayday,Adrian C
TI  - Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
SN  - 0008-5472
PY  - 2007///0911
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bone Density Conservation Agents
KW  - Diphosphonates
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Feasibility Studies
KW  - Humans
KW  - Imidazoles
KW  - Immunotherapy
KW  - methods
KW  - Interleukin-2
KW  - Lymphocyte Activation
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - Neoplasms, Hormone-Dependent
KW  - drug therapy
KW  - Prostatic Neoplasms
KW  - Receptors, Antigen, T-Cell, gamma-delta
KW  - Remission Induction
KW  - Salvage Therapy
KW  - T-Lymphocytes
KW  - cytology
KW  - Treatment Outcome
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/0008-5472.CAN-07-0199
ER  -